Bone Metastases and Health in Prostate Cancer: From Pathophysiology to Clinical Implications
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bone Metastases and Health in Prostate Cancer: From Pathophysiology to Clinical Implications
Authors
Keywords
-
Journal
Cancers
Volume 15, Issue 5, Pages 1518
Publisher
MDPI AG
Online
2023-02-28
DOI
10.3390/cancers15051518
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets
- (2022) Xintao Qiu et al. Nature Communications
- Epithelial and Stromal Characteristics of Primary Tumors Predict the Bone Metastatic Subtype of Prostate Cancer and Patient Survival after Androgen-Deprivation Therapy
- (2022) Pernilla Wikström et al. Cancers
- Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
- (2021) Oliver Sartor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and biological relevance of the transcriptomic‐based prostate cancer metastasis subtypes MetA‐C
- (2021) Elin Thysell et al. Molecular Oncology
- Oncological validation of bone turnover markers c-terminal telopeptide of type I collagen (1CTP) and peptides n-terminal propeptide of type I procollagen (P1NP) in patients with prostate cancer and bone metastases
- (2021) Stefan Aufderklamm et al. Translational Andrology and Urology
- Data independent acquisition-mass spectrometry (DIA-MS)-based comprehensive profiling of bone metastatic cancers revealed molecular fingerprints to assist clinical classifications for bone metastasis of unknown primary (BMUP)
- (2020) Xin Ku et al. Translational Cancer Research
- Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2020) C. Parker et al. ANNALS OF ONCOLOGY
- BONE HEALTH IN CANCER: ESMO CLINICAL PRACTICE GUIDELINES
- (2020) R. Coleman et al. ANNALS OF ONCOLOGY
- Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA
- (2020) Benedikt Feuerecker et al. EUROPEAN UROLOGY
- Optimizing antiresorptive treatment in patients with bone metastases: time to initiation, switching strategies, and treatment duration
- (2019) AnneMarthe Mjelstad et al. SUPPORTIVE CARE IN CANCER
- A positive role of c-Myc in regulating androgen receptor and its splice variants in prostate cancer
- (2019) Shanshan Bai et al. ONCOGENE
- Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
- (2019) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Matthew Smith et al. LANCET ONCOLOGY
- ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer
- (2019) Andrew J. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor
- (2019) Elin Thysell et al. Molecular Oncology
- Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer
- (2019) Ian D. Davis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
- (2019) Kim N. Chi et al. NEW ENGLAND JOURNAL OF MEDICINE
- C-C motif ligand 5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment
- (2018) Satoko Urata et al. CANCER SCIENCE
- Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
- (2018) Maha Hussain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
- (2018) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Update of the systematic review of palliative radiation therapy fractionation for bone metastases
- (2018) Shayna E. Rich et al. RADIOTHERAPY AND ONCOLOGY
- EAA clinical guideline on management of bone health in the andrological outpatient clinic
- (2018) V. Rochira et al. Andrology
- Metastatic bone disease: Pathogenesis and therapeutic options
- (2018) Stella D'Oronzo et al. Journal of Bone Oncology
- Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response
- (2017) Erik Bovinder Ylitalo et al. EUROPEAN UROLOGY
- A conduit to metastasis: circulating tumor cell biology
- (2017) Douglas S. Micalizzi et al. GENES & DEVELOPMENT
- Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases
- (2017) Andrew L. Himelstein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Beyond the vicious cycle: The role of innate osteoimmunity, automimicry and tumor-inherent changes in dictating bone metastasis
- (2017) Katie L. Owen et al. MOLECULAR IMMUNOLOGY
- Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
- (2017) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
- (2017) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Src and insulin/insulin-like growth factor-1 receptor (IR/IGF-1R) on tumors and bone turnover in prostate cancer (PCa) models in vivo compared with inhibition of either kinase alone.
- (2017) Farshid Dayyani et al. JOURNAL OF CLINICAL ONCOLOGY
- Dynamic modeling of bone metastasis, microenvironment and therapy
- (2016) Rui Moura Coelho et al. JOURNAL OF THEORETICAL BIOLOGY
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
- (2016) Nicholas D James et al. LANCET
- Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data
- (2016) Claire L Vale et al. LANCET ONCOLOGY
- Metastatic colonization by circulating tumour cells
- (2016) Joan Massagué et al. NATURE
- Recommandations en onco-urologie 2016-2018 du CCAFU : Cancer de la prostate
- (2016) F. Rozet et al. PROGRES EN UROLOGIE
- Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis
- (2016) F. Vescini et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Platelets at the interface of thrombosis, inflammation, and cancer
- (2015) A. T. Franco et al. BLOOD
- The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone
- (2015) Pierrick G.J. Fournier et al. CANCER CELL
- The Osteogenic Niche Promotes Early-Stage Bone Colonization of Disseminated Breast Cancer Cells
- (2015) Hai Wang et al. CANCER CELL
- VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-κB-induced endothelial activation
- (2015) Hua Huang et al. FASEB JOURNAL
- A 24-Month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density: Results From the ADAMO Trial
- (2015) Bente L. Langdahl et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
- (2015) Christopher J. Sweeney et al. NEW ENGLAND JOURNAL OF MEDICINE
- CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks
- (2015) F Guo et al. ONCOGENE
- Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage-Derived VEGFA
- (2015) A. S. Harney et al. Cancer Discovery
- The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer
- (2015) Debashish Sahay et al. Oncotarget
- Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms
- (2015) Mackenzie Herroon et al. Oncotarget
- GAS6/AXL Axis Regulates Prostate Cancer Invasion, Proliferation, and Survival in the Bone Marrow Niche
- (2015) Yusuke Shiozawa et al. NEOPLASIA
- Prevalence of Prostate Cancer Metastases after Intravenous Inoculation Provides Clues into the Molecular Basis of Dormancy in the Bone Marrow Microenvironment
- (2015) Younghun Jung et al. NEOPLASIA
- Expression of androgen receptor target genes in skeletal muscle
- (2014) Kesha Rana et al. ASIAN JOURNAL OF ANDROLOGY
- AR function in promoting metastatic prostate cancer
- (2014) Michael A. Augello et al. CANCER AND METASTASIS REVIEWS
- Differences of osteoblastic bone metastases and osteolytic bone metastases in clinical features and molecular characteristics
- (2014) J. Fang et al. Clinical & Translational Oncology
- TWIST1Expression in Breast Cancer Cells Facilitates Bone Metastasis Formation
- (2014) Martine Croset et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
- (2014) Gregory T Motz et al. NATURE MEDICINE
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
- (2014) Tomasz M. Beer et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Phase II Trial Evaluating Different Schedules of Zoledronic Acid on Bone Mineral Density in Patients With Prostate Cancer Beginning Androgen Deprivation Therapy
- (2013) Joshua M. Lang et al. Clinical Genitourinary Cancer
- The perivascular niche regulates breast tumour dormancy
- (2013) Cyrus M. Ghajar et al. NATURE CELL BIOLOGY
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D
- (2013) S. M. H. Alibhai et al. OSTEOPOROSIS INTERNATIONAL
- RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients
- (2013) L A Kachnic et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Serum sclerostin levels in Paget's disease and prostate cancer with bone metastases with a wide range of bone turnover
- (2012) Maria P. Yavropoulou et al. BONE
- Integrin alpha2beta1 (α2β1) promotes prostate cancer skeletal metastasis
- (2012) Joseph L. Sottnik et al. CLINICAL & EXPERIMENTAL METASTASIS
- N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors
- (2012) B. Gligorijevic et al. JOURNAL OF CELL SCIENCE
- Long-Term Dynamics of Bone Mineral Density During Intermittent Androgen Deprivation for Men With Nonmetastatic, Hormone-Sensitive Prostate Cancer
- (2012) Evan Y. Yu et al. JOURNAL OF CLINICAL ONCOLOGY
- Depletion of Plasmacytoid Dendritic Cells Inhibits Tumor Growth and Prevents Bone Metastasis of Breast Cancer Cells
- (2012) Anandi Sawant et al. JOURNAL OF IMMUNOLOGY
- Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial
- (2012) Christopher J Logothetis et al. LANCET ONCOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Macrophage cathepsin K promotes prostate tumor progression in bone
- (2012) M K Herroon et al. ONCOGENE
- Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases
- (2011) F. Saad et al. ANNALS OF ONCOLOGY
- VCAM-1 Promotes Osteolytic Expansion of Indolent Bone Micrometastasis of Breast Cancer by Engaging α4β1-Positive Osteoclast Progenitors
- (2011) Xin Lu et al. CANCER CELL
- Stem Cell Quiescence
- (2011) L. Li et al. CLINICAL CANCER RESEARCH
- Myeloid-Derived Suppressor Cells: General Characteristics and Relevance to Clinical Management of Pancreatic Cancer
- (2011) P. Goedegebuure et al. CURRENT CANCER DRUG TARGETS
- TGF-β Signaling in Breast Cancer Cell Invasion and Bone Metastasis
- (2011) Yvette Drabsch et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Factors Associated With Vertebral Fractures in Men Treated With Androgen Deprivation Therapy for Prostate Cancer
- (2011) Philip J. Saylor et al. JOURNAL OF UROLOGY
- Osteoblast retraction induced by adherent neutrophils promotes osteoclast bone resorption: implication for altered bone remodeling in chronic gout
- (2011) Isabelle Allaeys et al. LABORATORY INVESTIGATION
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation
- (2011) Sachie Hiratsuka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis
- (2011) A Serpa Neto et al. PROSTATE CANCER AND PROSTATIC DISEASES
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- Pathogenesis of osteoblastic bone metastases from prostate cancer
- (2010) Toni Ibrahim et al. CANCER
- The transcriptomics of de novo androgen biosynthesis in prostate cancer cells following androgen reduction
- (2010) Jinrong Cheng et al. CANCER BIOLOGY & THERAPY
- Matrix Metalloproteinases Contribute Distinct Roles in Neuroendocrine Prostate Carcinogenesis, Metastasis, and Angiogenesis Progression
- (2010) L. E. Littlepage et al. CANCER RESEARCH
- Metastatic Growth from Dormant Cells Induced by a Col-I-Enriched Fibrotic Environment
- (2010) D. Barkan et al. CANCER RESEARCH
- Predictors of survival in patients with prostate cancer and spinal metastasis
- (2010) Dan Michael Drzymalski et al. JOURNAL OF NEUROSURGERY-SPINE
- Fracture Types and Risk Factors in Men With Prostate Cancer on Androgen Deprivation Therapy: A Matched Cohort Study of 19,079 Men
- (2010) Shabbir M.H. Alibhai et al. JOURNAL OF UROLOGY
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Selectins promote tumor metastasis
- (2010) Heinz Läubli et al. SEMINARS IN CANCER BIOLOGY
- Titration of Dosage for the Protective Effect of Zoledronic Acid on Bone Loss in Patients Submitted to Androgen Deprivation Therapy due to Prostate Cancer: A Prospective Open-Label Study
- (2010) Paulo Rodrigues et al. UROLOGIA INTERNATIONALIS
- Bone-marker levels in patients with prostate cancer: potential correlations with outcomes
- (2010) Fred Saad et al. Current Opinion in Supportive and Palliative Care
- Long-term effects of intermittent androgen suppression on testosterone recovery and bone mineral density: results of a 33-month observational study
- (2009) Nigel A. Spry et al. BJU INTERNATIONAL
- Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche
- (2009) Janine T. Erler et al. CANCER CELL
- Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization
- (2009) Massimiliano Mazzone et al. CELL
- Intravenous Zoledronic Acid to Prevent Osteoporosis in a Veteran Population With Multiple Risk Factors for Bone Loss on Androgen Deprivation Therapy
- (2009) Nirmala Bhoopalam et al. JOURNAL OF UROLOGY
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment thresholds for osteoporosis in men on androgen deprivation therapy: T-score versus FRAX™
- (2009) R. A. Adler et al. OSTEOPOROSIS INTERNATIONAL
- Anti-cancer properties of low-molecular-weight heparin: Preclinical evidence
- (2009) Lars Petersen et al. THROMBOSIS AND HAEMOSTASIS
- Incidence and risk factors for low trauma fractures in men with prostate cancer
- (2008) Henrik G. Ahlborg et al. BONE
- Annexin II/Annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer
- (2008) Yusuke Shiozawa et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Skeletal Health After Continuation, Withdrawal, or Delay of Alendronate in Men With Prostate Cancer Undergoing Androgen-Deprivation Therapy
- (2008) Susan L. Greenspan et al. JOURNAL OF CLINICAL ONCOLOGY
- Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA
- (2008) B. Dawson-Hughes et al. OSTEOPOROSIS INTERNATIONAL
- Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis
- (2008) Christopher L. Hall et al. PROSTATE
- Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
- (2007) Ronald J Buckanovich et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now